<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04836078</url>
  </required_header>
  <id_info>
    <org_study_id>Simvastatin in periodontitis</org_study_id>
    <nct_id>NCT04836078</nct_id>
  </id_info>
  <brief_title>Role of Simvastatin Microsponges in Treatment of Periodontitis</brief_title>
  <official_title>Performance of Simvastatin Microsponges as a Local Treatment for Chronic Periodontitis - Randomized Clinical Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assiut University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assiut University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      the aim of our study is to enhance the dissolution and subsequently the local penetration of&#xD;
      the drug through the sulcus in addition to controlling the drug release so that, the drug&#xD;
      could be potentially absorbed.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients will be divided randomly into three groups: Group (I);will be treated with&#xD;
      subgingival debridement and subgengival injection of chitosan 2% gel containing a&#xD;
      microsponges formulated (SV), Group (II); will be treated with subgingival debridement and&#xD;
      subgingival injection of chitosan 2% gel containing free (SV) and Group (III); will be&#xD;
      treated by subgingival debridement and placebo gel injected subgingivally. Pocket depth and&#xD;
      clinical attachment loss bone gain were recorded preoperative and six months postoperative&#xD;
      for all groups.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">February 10, 2020</start_date>
  <completion_date type="Actual">October 10, 2020</completion_date>
  <primary_completion_date type="Actual">August 10, 2020</primary_completion_date>
  <phase>Early Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Pocket depth</measure>
    <time_frame>Before the beginning of study</time_frame>
    <description>Will be measured in millimetre</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Pocket depth</measure>
    <time_frame>By the end of study after 6 months of 6 months</time_frame>
    <description>Will be measured in millimetre</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Clinical attachment loss</measure>
    <time_frame>Before beginning of the study</time_frame>
    <description>Will be measured in millimetre</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Clinical attachment loss</measure>
    <time_frame>By the end of study after 6 months of 6 months</time_frame>
    <description>Will be measured in millimetre</description>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">24</enrollment>
  <condition>Periodontitis</condition>
  <arm_group>
    <arm_group_label>Plain chitosan gel group</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>After the reevaluation phase after that corrective surgical phase started for the three groups. Local infiltration anesthesia administrated then sulcular flaps raised for the purpose of open flap subgingival debridement . Randomization will be performed and concealment from the assessors. For root conditioning purpose, Group (I) ; will be injected subgingivally with chitosan 2% gel .</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Chitosan gels containing free Simvastatin</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Will be injected subgingivally with simvastatin microsponges dispersed into chitosan 2% gel. .</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Chitosan gels containing Simvastatin microsponges</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>This group will be injected subgingivally with free simvastatin dispersed into chitosan 2% gel containing .</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>open flap subgingival debridement</intervention_name>
    <description>After the reevaluation phase after that corrective surgical phase started for the three groups. Local infiltration anesthesia administrated then sulcular flaps raised for the purpose of open flap subgingival debridement.Randomization was then performed and concealment from the assessors.</description>
    <arm_group_label>Chitosan gels containing Simvastatin microsponges</arm_group_label>
    <arm_group_label>Chitosan gels containing free Simvastatin</arm_group_label>
    <arm_group_label>Plain chitosan gel group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Subgingival injection of chitosan 2% gel</intervention_name>
    <description>Group (I); injected subgingivally with chitosan 2% gel containing a microsponges formulated drug weekly</description>
    <arm_group_label>Plain chitosan gel group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Subgingival injection of chitosan 2% gel</intervention_name>
    <description>Group (II); injected subgingivally with chitosan 2% gel containing free drug weekly</description>
    <arm_group_label>Chitosan gels containing free Simvastatin</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Subgingival injection of chitosan 2% gel</intervention_name>
    <description>Group (III); injected subgingivally with placebo chitosan 2% gel weekly</description>
    <arm_group_label>Chitosan gels containing Simvastatin microsponges</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  patients with chronic periodontitis with minimum two sites of pocket depth &gt; 5 mm&#xD;
&#xD;
          -  patients with normal lipid profile&#xD;
&#xD;
          -  nonsmokers&#xD;
&#xD;
          -  patients free from any systemic disorders&#xD;
&#xD;
          -  committed patients to complete the treatment with follow-ups.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  patients with hyperlipidemia&#xD;
&#xD;
          -  patients taking lipid lowering drugs&#xD;
&#xD;
          -  smokers&#xD;
&#xD;
          -  pregnant&#xD;
&#xD;
          -  Lactating women women, patients with mental or psychological illness and medically&#xD;
             compromised patients.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>30 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Assiut University</name>
      <address>
        <city>Assuit</city>
        <zip>71111111</zip>
        <country>Egypt</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>April 2021</verification_date>
  <study_first_submitted>March 25, 2021</study_first_submitted>
  <study_first_submitted_qc>April 5, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">April 8, 2021</study_first_posted>
  <last_update_submitted>April 5, 2021</last_update_submitted>
  <last_update_submitted_qc>April 5, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">April 8, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Assiut University</investigator_affiliation>
    <investigator_full_name>Ahmed Mortada</investigator_full_name>
    <investigator_title>Lecturer at the Department of Periodontology and Oral Implantology , Faculty of Dentistry , Assiut University, Egypt</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Periodontitis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Chitosan</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

